CASE REPORT
A 46-year-old Japanese woman presented with vesicles on her nose and the dosal aspect of her hands since 3 months. Physical examination revealed tense blisters and atrophic erythematous plaques on her arms and the dosal side of her hands (Fig. 1a) . Erosions were also scattered on the face (Fig. 1b) . She also had hypertrichosis on her face. The patient was first diagnosed as having systemic lupus erythematosus (SLE) in 1997 at the age of 41 years, when she presented with alopecia, fever, arthralgia, Raynaud's phenomenon, hemolytic anemia and lymphadenopathy. Liver transamirase levels were slightly elevated. She had no sign of hepatitis including autoimmune hepatitis, drug-related hepatotoxity, alcoholic hepatitis, or viral infection. Systemic lupus eryhtematosus was well-controlled with a daily 5-mg dose of prednisolone (PSL).
At age of 43 years she developed erythematous plaques with scaling on the back of her hands. Clinically the skin erupution at that time appeared to be discoid lupus erythematodes. She was treated with a steroid ointment and her eruptions gradually improved, but new skin lesions repeatedly appeared on her hands. Association of SLE and PCT is not common, and this combination usually poses practical problems and occasionally therapeutic dilemmas.
Phlebotomy is one treatment for PCT, but it is not advisable in LE patients who have anemia. Antimalarials are used for the treatment of LE and PCT.
Severe toxicity can result from using high dose of chloroquine (8) , and hydroxichloroquine may also be associated with abdominal crises in some cases. (9) . However, low-dose chloroquine therapy has been shown to be effective without causing serious hepatotoxicity (10) . Therefore, it is important to avoid high-dose chloroquine therapy in cases of joint LE and PCT.
Our patient's skin lesion and the quantity of porphyrines in her urine have been improved since she started the avoidance of sun exposure together with the topical steroid ointment treatment. Strict total sun protection should be recommended to patients with PCT and SLE because both conditions can be activated by long wavelength light bound in sunlight. 
